Viemed Healthcare, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDViemed Healthcare, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 89), indicating clear outperformance against the broad market. However, with RSI at 77, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $10.90 | +11.26% | ABOVE |
| 50 SMA | $10.11 | +19.94% | ABOVE |
| 100 SMA | $9.61 | +26.27% | ABOVE |
| 150 SMA | $8.86 | +36.87% | ABOVE |
| 200 SMA | $8.32 | +45.85% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VMD in an uptrend right now?
VMD has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, VMD is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is VMD overbought or oversold?
VMD's RSI (14) is 77. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is VMD outperforming the market?
VMD has a Relative Strength (RS) Rating of 89 out of 99. Yes, VMD is a market leader, outperforming 89% of all stocks over the past 12 months.
Where is VMD in its 52-week range?
VMD is trading at $12.13, which is 98% of its 52-week high ($12.43) and 95% above its 52-week low ($5.93).
How volatile is VMD?
VMD has a Beta of 0.56 and 52-week volatility of 39%. It's less volatile than the S&P 500 - generally more stable.